Zanamivir
Important Notice: For research use only. We do not sell to patients.
Not your Region? View all Distributors
Important Notice: For research use only. We do not sell to patients.
Not your Region? View all Distributors
Discription | Zanamivir is a neuraminidase inhibitor used in the treatment and prophylaxis of influenza caused by influenza A virus and influenza B virus. | ||
---|---|---|---|
Targets |
|
Catalog Num | A11613 |
---|---|
Formula | C12H20N4O7 |
Molecular Weight | 332.31 |
CAS Number | 139110-80-8 |
SMILES | CC(=O)N[C@@H]1[C@H](C=C(O[C@H]1[C@@H]([C@@H](CO)O)O)C(=O)O)N=C(N)N |
Synonyms | Relenza |
Storage | Store lyophilized at -20ºC, keep desiccated. |
In vitro | DMSO | 2 mg/mL (6.01 mM) | |
Water | 25 mg/mL (75.23 mM) | ||
Ethanol | Insoluble | ||
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 30.09 mL | 150.46 mL | 300.92 mL |
0.5 mM | 6.02 mL | 30.09 mL | 60.18 mL |
1 mM | 3.01 mL | 15.05 mL | 30.09 mL |
5 mM | 0.6 mL | 3.01 mL | 6.02 mL |
Calculate the dilution required to prepare a stock solution. This equation is commonly abbreviated as: C1V1 = C2V2